Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Os Therapies announced it raised $5 Million in an initial filing from an offering of $10 Million
PUBLIC · OSTXAug 25, 2026•about 6 hours ago
Amount Raised
$5 Million
Round Type
Venture - Series Unknown
New YorkBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma
Company Information
Company
Os Therapies
Location
New York, New York, United States
About
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.
Don't miss Os Therapies's next move
Get an email the moment Os Therapies raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts hidden hidden hidden hidden
Predictive Intelligence
Strategic
ML-powered predictions for Os Therapies's next move